CORE CAPABILITIES
Corporate Performance Brand Analysis And Monitoring
Investors rely on Wall Street and hedge fund analysts to predict asset performance trends. Our market research delivers critical insights and brand monitoring for a clear view of company performance. Smaller pharmaceutical companies with a few rare disease treatments are particularly affected by shifts in patient and thought leader sentiment.
Staying updated on treatment adoption trends, community sentiment, and competitive messaging in rare disease markets gives your investment analyst team a decisive edge over traditional valuation methods.
Due Diligence for Mergers and Acquisitions
Optio provides due diligence for pharma M&A, offering commercial experience and market research to help your BD team assess small molecules or biologics. We can deliver quick assessments or comprehensive evaluations across key market stakeholders, including clinicians, thought leaders, patient/caregiver community, patient advocates and influencers, to provide both a broad and objective perspective.
Leveraging Optio before concluding your pharma M&A deal will bring your asset evaluation into clearer focus.
Pharma Market Research
Optio excels in both qualitative and quantitative methodologies, including handling international market research for pharma clients. While most our work is in the US, our research operations have involved every continent except Africa and Antarctica. We are especially experienced with rare disease projects and adept at engaging with all key stakeholders in those markets from patients/parents to thought leaders.
Our deeply experienced researchers are involved at every stage, with no hand-offs to junior staff.
Brand Management
Brand teams are often beset by staffing gaps: leadership promotions, parental leave, and hiring delays can produce bottlenecks in the flow of work vital to brand success. It is a truism that brand teams usually experience limits in work bandwidth in the frenetic year leading up to product launch.
Optio can provide senior level expertise capable of immediately adding value to any brand team. Optio can fill gaps in brand team staffing or increase your team’s capabilities.
NPP - Strategic Planning
Our new product planning (NPP) approach adapts the classic large-pharma strategic model for smaller pharma and biopharmaceutical companies. Strategic commercial planning is essential for success, but often delayed due to staffing or workload challenges. Optio provides solutions to these challenges.
Pharmaceutical companies entering phase 2 without expert NPP work risk commercial pitfalls. The importance of a coherent strategic plan, informed by market research, grows until launch. Let’s meet and discuss how we can help.
Rare Disease Markets
Optio excels in rare disease markets, with clients relying on us for market research and strategic work for their orphan drugs. Our clients, often innovators, face uncharted markets with limited prescription and prescriber data, unresolved prevalence figures, and diagnosis delays.
Our experienced and creative staff excel in market planning and research for rare disease therapeutics. We also understand specialty pharmacy distribution and patient support programs, often integrating them with commercial strategy. Let’s meet and discuss how we can help.
Clinical Trial Awareness And Patient-focused Optimization
Driving awareness, including for clinical trials, demands marketing expertise. Optio partners excel at optimizing patient and care-partner communications, from branded trial websites to enrollment forms, while meeting rigorous reviews from chief investigators and IRBs.
Our partners have successfully turned around clinical trial enrollment deemed insurmountable by the investment community and short-selling analysts, drastically improving sentiment and enrollment for others.
Other Commercial Services
Broad commercial know-how, deep expertise, integrated services, and global reach is how we describe our capabilities. Our clients have turned to us for unique work that requires deep knowledge across an array of cross-functional roles. Some examples include commercial support of business development efforts leading to a successful out- licensing; the design, development, and market research of patient-friendly packaging from concept to launch ready prototype; and a strategically critical thought leader research project with a two week turn around.
Let us know how we can help with your unique commercial need.
ABOUT US
Optio provides comprehensive commercial know-how, deep cross-functional expertise, and strategically integrated services with a global reach.
While the majority of biopharma companies are staffed to a level capable of providing comprehensive corporate strategy and vision, the ever increasing project workload and operational scope required for success can be daunting. Optio will provide the additional expertise and work capacity critical to your company’s success.
Optio has delivered quality market research, NPP – strategic planning, competitive intelligence, and provided other customized commercial pharmaceutical services to US, European, Chinese, and Japanese healthcare companies since 2010.
Optio Biopharma Solutions specializes in providing biopharmaceutical companies with comprehensively experienced marketing and strategic commercial support – a supplementary on-demand proficiency or “right hand” to you and your team. Optio can provide additional strategic insight, operational expertise, or implement tactics.